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The electron ionization mass spectra of l-cyclopropyl-4-substituted-l,2,3,6-tetrahydropyridine 
derivatives are characterized by a base peak corresponding to [M-151+. Evidence is presented 
to support a fragmentation process involving an initial cyclopropyl ring opening of the parent 
cyclopropylaminyl radical cation followed by intramolecular transfer of a hydrogen atom from 
the ring carbon atoms a! to nitrogen to the primary carbon-centered radical and finally a 
fragmentation step proceeding by loss of a methyl radical and formation of a stable 
N-ethenyldihydropyridinium ion, the [M-15]+ fragment. (J Am Sot Mass Spectrom 1997, 8, 
724-726) 0 1997 American Society for Mass Spectrometry 
D uring the course of our studies on the pathway for monoamine oxidase (MAO) catalysis, we have prepared the 1-cyclopropyl analog 1 of 
1-methyl-4-phenyl-1,2,3,6tetrahydropyridine [MPTP (lo), 
Table 11, a neurotoxin that undergoes MAO-B catalyzed 
bioactivation 111. The electron ionization (EI) mass 
spectrum of 1 displayed a base peak corresponding to 
the loss of 15 u [2]. An analogous fragment ion had not 
been observed in the spectra of a variety of l-methyl- 
tetrahydropyridine derivatives [3, 41. We present here 
the results of our studies on the mass spectral charac- 
teristics of 1 and several analogs of 1 bearing different 
C-4 substituents, all but one of which undergo a similar 
fragmentation reaction. The results of these studies 
together with those obtained with selectively labeled 
deuterium analogs of 1 have led to a proposed mecha- 
nism to account for the formation of the [M-15]+ 
fragment. 
Experimental 
Compounds 
The tetrahydropyridine derivatives examined in this 
study were synthesized in our laboratory and exhibited 
satisfactory spectral characteristics and elemental anal- 
ysis ]2, 4-71. The deuterium enrichments of the labeled 
compounds were >98% and the expected regioselectiv- 
ity was confirmed by 400 MHz ‘H NMR spectra anal- 
ysis [8]. 
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Instrumentation 
EI mass spectra (350-50 u) were recorded using a VG 
Analytical 7070 E-HF mass spectrometer at 70 eV with 
the source temperature fixed at 200 “C. Studies on the 
variations in ion intensities as a function of ionization 
energy were performed on a VG Fisons Quattro mass 
spectrometer. At least four spectra of each compound 
were obtained within a short period of time. Tests with 
reference gas before and after the experiments con- 
firmed the stability of the spectrometers. 
Results and Discussion 
Inspection of the EI mass spectra of the l-cyclopropyl- 
4-substituted-1,2,3,6tetrahydropyridine analogs re- 
vealed in every case but one a base peak at an m/z value 
corresponding to [M-15]+. As a typical example, the 
spectrum of 1-cyclopropyl-4-phenyl-1,2,3,6-tetrahydro- 
pyridine (1) is shown on Figure 1. In contrast to the 
behavior of other 1,4-disubstituted 1,2,3,6-tetrahydro- 
pyridine derivatives [3, 5, 9, 101, the intensities of the 
fragment ions corresponding to the loss of one u were 
uniformly weak. The relative ion intensities corre- 
sponding to M”, [M-l]+, and [M-15]’ for a series of 
nine I-cyclopropyltetrahydropyridine derivatives l-9 
(Scheme I) bearing various groups at C-4, obtained 
under the conditions described in the experimental 
section, are provided in Table 1. For comparison, the 
ratios for the N-methyl- and N-propyl-4-phenyl-1,2,3,6- 
tetrahydropyridine analogs 10 and 11 are also reported. 
These compounds do not exhibit significant [M-15]+ 
fragment but undergo loss of hydrogen from the carbon 
Q to the nitrogen instead. The absence of [M-151+ 
supports a fragmentation mechanism specific to the 
N-cyclopropyl analogs. 
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Table 1. Relative abundances of peaks [Ml’+, [M-l]+, and 
[M-15]+ for various C-4 substituted I-cyclopropyl-1,2,3,6-tetrahy- 
dropyridine derivatives and the l-methyl (10) and 1-propyl (11) 
derivatives 
C-Csubstituent 
Phenyl 
p-Phenylphenyl 
P-Naphthyl 
Benzyl 
Phenoxy 
Thiophenoxy 
4-Pyridyl 
I-Methyl-2-pyrrolyl 
P-Benzotriazolyl 
Phenyl (l-methyl) 
Phenyl (l-propyl) 
aNot detected. 
[Ml [M-l1 [M-151 
1 44 7 100 
2 59 8 100 
3 65 8 100 
4 49 7 100 
5 34 4 100 
6 47 4 100 
7 42 8 100 
8 58 6 100 
9 47 7 100 
10 100 70 2 
11 100 32 NDa 
A possible pathway that would account for the loss 
of 15 u from cyclopropylamines is shown in Scheme I 
and is based on the known ease with which cyclopro- 
pylcarbinyl radicals 111-131, and cyclopropylaminyl 
radical cations 114,151, undergo ring opening, a reaction 
driven by the release of the cyclopropyl ring strain 
energy 1161. Initial ionization of the amine analytes l-9 
leads to the parent cyclopropylaminyl radical cations i 
which ring open to generate the primary carbon cen- 
tered radicals ii/iii. These unstable intermediates rear- 
range by a 1,6-hydrogen atom shift from the carbon 
atoms QI to the ring nitrogen to form the stabilized 
allylic radicals iv/v. Loss of a methyl radical from iv/v 
leads to the stable dihydropyridinium fragment ions 
vi/vii corresponding to an m/z value of [M-15]+. 
In order to evaluate this proposed pathway, the EI 
mass spectrum of the 2,2,6,6-d, analog 1-2,2,6,6-d, of 
l-cyclopropyl-4-pheny1-1,2,3,6-tetrahydropyridine (1) 
was examined (Figure 2) [B]. Consistent with the pro- 
posed pathway, the base peak for this molecule ap- 
peared at an m/z value corresponding to [M-16]‘. The 
analogous base peaks were also observed for the corre- 
sponding 4-benzyl (4-2,2,6,6-d,), 4-phenoxy (5-2,2,6,6- 
d,) and 4-(1-methyl-2-pyrrolyl) (8-2,2,6,6-d,) deuterated 
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Scheme I. Proposed mechanism to account for the [M-15]+ 
fragment observed in l-cyclopropyl-4-substituted-1,2,3,6-tetrahy- 
dropyridines. 
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Figure 1. The EI-mass spectrum (70 eV) of I-cyclopropyl-C 
phenyl-1,2,3,6-tetrahydropyridine (1). 
analogs (Scheme II). We also examined the EI mass 
spectrum of the 1-6,6-d, analog to determine the regio- 
selectivity of the hydrogen atom transfer reaction [B, 
171. Both the [M-15]+ and [M-16]+ peaks were detected 
although, as can be expected in regard to the relative 
energies of the two types of C-H bonds, formation of 
the allylic radical l-iv was favored over the homoallylic 
radical l-v (Table 2). Evidence that the [M-l]+ fragment 
was not due to a residue of 1 labeled with three 
deuterium atoms only came from the MS-MS of [M-l]’ 
and [Ml’+ ions that gave different spectra. This also 
suggests that the [M-l]+ in these compounds does not 
completely originate from a-hydrogen loss as known in 
the piperidine system [18,19], and that a more compli- 
cated mechanism takes place. Since loss of 15 u also was 
observed with the corresponding saturated analog l-cy- 
clopropyl-4-phenylpiperidine (12), the reaction se- 
quence shown in Scheme I is not dependent on the 
double bond present in the tetrahydropyridine ring. 
In order to gain information on the appearance of the 
[M-15]+ fragment, variations of the energy of ionization 
were performed on 1 from 70 eV down to 5 eV. Even at 
very low ionization energies, the [M-151+ remained a 
major fragment demonstrating that the ring opening was 
always a favored pathway of fragmentation. As expected, 
the relative intensity of other fragments of lower molecu- 
lar weight decreased as the ionization energy decreased. 
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Figure 2 The EI-mass spectrum (70 eV) of tetradeuterated l-cyclo- 
propyl+phenyl-l,2,3,6-tetrahydropyridine2,2,6,6-d, (1-2,2,6,6-d,). 
726 MABIC ET AL. J Am Sot Mass Spectrom 1997, 8, 724-726 
1-2,2,6,6-d.,: R = Phenyl; R’ = D 
1-6,6-d,: R = Phenyl; R’ = H 
12 
4-2,2,6,6+: R = Benzyl; R’ = D 
5-2,2,6,6-d4: R = Phenoxy; R’ = D 
8-2,2,6,6-d4: R =I-MethyWpyrrolyl; R’ = D 
Scheme II. Deuterated N-cyclopropyl tetrahydropyridine and 
piperidine analogs. 
The fragmentation pathway proposed in Scheme I 
applies to all of the 4-substituted l-cyclopropyltetrahy- 
dropyridine derivatives examined so far (about 40) but 
one. This exception is the 4-(l-benzotriazolyl) derivative 
13 for which the base peak is [M-29]+; the relative inten- 
sity of the [M-15]+ ion is 10%. This is in contrast to the 
4-(2-benzotriazolyl) analog 9 which exhibits the typical 
[M-15]+ base peak common to all other N-cyclopropyl 
derivatives. Consideration of earlier literature reports [20] 
suggests that in the case of 13 the driving force leading to 
the [M-29]+ fragment is initiated by the formation of the 
parent radical cation 14 followed by the loss of N2. A 
possible mechanism leading to a stable [M-29]+ ion is 
depicted in Scheme III. The final loss of hydrogen is 
supported by deuterium labeling studies. Indeed, both 
[M-29]+ and [M-30]+ fragments (67% and 33%, respec- 
tively) are observed with 13-2,6-d,. Studies on the 
variations of energy of ionization were also performed 
with 13 in order to try to increase the relative ionization 
at the N-cyclopropyl center. The loss of nitrogen, how- 
ever, remained the main fragmentation pathway. 
Conclusion 
We propose that cyclopropylaminyl radical cations gen- 
erated under EI conditions undergo a reaction pathway 
involving ring opening, hydrogen atom transfer, and 
loss of a methyl radical to account for the [M-151+ base 
peak observed. This process is fast, happens even at low 
ionization energy, and is associated with little hydrogen 
scrambling. The double bond is not necessary for this 
rearrangement to occur. 
Table 2. Relative ratio of [Ml’+, [M-l]+, [M-Z]+, [M-151+, and 
[M-16]+ peaks of deuterated and saturated analogs of 1 (values 
corrected for ‘%Z isotope) 
Compound [Ml (M-151 [M-161 (M-11 [M-21 
l-d, 44 100 - 6 - 
1-2,2,6,6-d, 51 6 100 4 3 
1-2,2-d, 57 100 28 7 - 
12" 17 24 - 4 - 
“[M-291+ was the base peak in this case and not [M-15]+. 
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Scheme III. Proposed fragmentation of 4-(l-benzotriazolyl) de- 
rivative 13. 
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